Lisa Christopher-Stine, Fredrick Wigley. Show Affiliations »
Abstract
Entities: Disease Gene Species
Mesh: See more » AdultAntibodies, Monoclonal/adverse effectsAntirheumatic Agents/adverse effectsArthritis/complicationsArthritis/drug therapyArthritis/pathologyFemaleHumansInfliximabLupus Erythematosus, Systemic/chemically inducedLupus Erythematosus, Systemic/complicationsLupus Erythematosus, Systemic/pathologyMaleMixed Connective Tissue Disease/complicationsMixed Connective Tissue Disease/drug therapyMixed Connective Tissue Disease/pathologyScleroderma, Systemic/complicationsScleroderma, Systemic/drug therapyScleroderma, Systemic/pathologyTumor Necrosis Factor-alpha/agonists
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsTumor Necrosis Factor-alphaInfliximab
Year: 2003 PMID: 14719225
Source DB: PubMed Journal: J Rheumatol ISSN: 0315-162X Impact factor: 4.666